These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14629833)

  • 1. Somatostatin receptor (SSTR) scintigraphy in patients with osteosarcoma.
    Ferrari S; Dondi M; Fanti S; Zoboli S; Giacomini S; Mercuri M; Bacci G
    Cancer Biother Radiopharm; 2003 Oct; 18(5):847-51. PubMed ID: 14629833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A possible role for somatostatin receptor scintigraphy in the diagnosis and follow-up of children with medulloblastoma.
    Müller HL; Frühwald MC; Scheubeck M; Rendl J; Warmuth-Metz M; Sörensen N; Kühl J; Reubi JC
    J Neurooncol; 1998 May; 38(1):27-40. PubMed ID: 9540055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of lung metastases from osteosarcoma by scintigraphy using 99mTc-methylene diphosphonate.
    Hoefnagel CA; Bruning PF; Cohen P; Marcuse HR; van der Schoot JB
    Diagn Imaging; 1981; 50(5):277-84. PubMed ID: 6457735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin receptor profiling in hepatic metastases from small intestinal and pancreatic neuroendocrine neoplasms: immunohistochemical approach with potential clinical utility.
    Nasir A; Stridsberg M; Strosberg J; Su PH; Livingston S; Malik HA; Kelley ST; Centeno BA; Coppola D; Malafa ME; Yeatman TJ; Kvols LK
    Cancer Control; 2006 Jan; 13(1):52-60. PubMed ID: 16508627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An orthotopic model of pancreatic somatostatin receptor (SSTR)-positive tumors allows bimodal imaging studies using 3T MRI and animal PET-based molecular imaging of SSTR expression.
    Stelter L; Amthauer H; Rexin A; Pinkernelle J; Schulz P; Michel R; Denecke T; Stiepani H; Hamm B; Wiedenmann B; Scholz A
    Neuroendocrinology; 2008; 87(4):233-42. PubMed ID: 18025811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy.
    Lebtahi R; Cadiot G; Delahaye N; Genin R; Daou D; Peker MC; Chosidow D; Faraggi M; Mignon M; Le Guludec D
    J Nucl Med; 1999 Oct; 40(10):1602-8. PubMed ID: 10520698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of somatostatin receptors in inflammatory lesions and diagnostic value of somatostatin receptor scintigraphy in patients with ANCA-associated small vessel vasculitis.
    Neumann I; Mirzaei S; Birck R; Osinger K; Waldherr R; Köhn HD; Meisl FT
    Rheumatology (Oxford); 2004 Feb; 43(2):195-201. PubMed ID: 12949255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors.
    Krausz Y; Bar-Ziv J; de Jong RB; Ish-Shalom S; Chisin R; Shibley N; Glaser B
    Am J Gastroenterol; 1998 Jan; 93(1):66-70. PubMed ID: 9448177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo inaccessibility of somatostatin receptors to 111In-pentreotide in primary renal cell carcinoma.
    Montravers F; Rousseau C; Doublet JD; Gattengo B; Allard S; Fouret P; Bernaudin JF; Thibault P; Talbot JN
    Nucl Med Commun; 1998 Oct; 19(10):953-61. PubMed ID: 10234675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type.
    Raderer M; Traub T; Formanek M; Virgolini I; Osterreicher C; Fiebiger W; Penz M; Jäger U; Pont J; Chott A; Kurtaran A
    Br J Cancer; 2001 Nov; 85(10):1462-6. PubMed ID: 11720429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carcinoid tumor and bone metastases: diagnosis by somatostatin receptor scintigraphy].
    Banzo J; Abós MD; Prats E; Razola P; García S; Alonso V; Velilla J; García F; Ubieto MA; Tardín L
    Rev Esp Med Nucl; 2004; 23(6):394-402. PubMed ID: 15625056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin analogs and radiopeptides in cancer therapy.
    Froidevaux S; Eberle AN
    Biopolymers; 2002; 66(3):161-83. PubMed ID: 12385036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.
    Gabriel M; Decristoforo C; Donnemiller E; Ulmer H; Watfah Rychlinski C; Mather SJ; Moncayo R
    J Nucl Med; 2003 May; 44(5):708-16. PubMed ID: 12732671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin receptor scintigraphy in medullary thyroid carcinoma.
    Tisell LE; Ahlman H; Wängberg B; Hansson G; Mölne J; Nilsson O; Lindstedt G; Fjälling M; Forssell-Aronsson E
    Br J Surg; 1997 Apr; 84(4):543-7. PubMed ID: 9112914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of somatostatin receptor scintigraphic imaging (octreoscan) in esthesioneuroblastoma: a case study and survey of somatostatin receptor subtype expression.
    Rostomily RC; Elias M; Deng M; Elias P; Born DE; Muballe D; Silbergeld DL; Futran N; Weymuller EA; Mankoff DA; Eary J
    Head Neck; 2006 Apr; 28(4):305-12. PubMed ID: 16470879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
    Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
    Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
    Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of 99mTc(V)-DMSA scan as compared to 99mTc-MDP and CT scans in imaging the primary tumor and metastases of osteosarcoma.
    Zissimopoulos A; Zanglis A; Andreopoulos D; Baziotis N
    Hell J Nucl Med; 2005; 8(3):162-4. PubMed ID: 16390022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inferior outcome of neuroendocrine tumor patients negative on somatostatin receptor imaging.
    Refardt J; Zandee WT; Brabander T; Feelders RA; Franssen GJH; Hofland LJ; Christ E; de Herder WW; Hofland J
    Endocr Relat Cancer; 2020 Nov; 27(11):615-624. PubMed ID: 33032265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thallium-201 scintigraphy for the evaluation of tumor response to preoperative chemotherapy in patients with osteosarcoma.
    Imbriaco M; Yeh SD; Yeung H; Zhang JJ; Healey JH; Meyers P; Huvos AG; Larson SM
    Cancer; 1997 Oct; 80(8):1507-12. PubMed ID: 9338476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.